Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNHD1 DYNC2H1 DNAH1	3.12e-05	18	208	4	GO:0008569
GeneOntologyMolecularFunction	small GTPase binding	LRRK2 RTKN RPTOR RIN2 DIAPH3 RIC1 ANKFY1 ASB14 ASB15 APPL2 DEPDC5 TNFAIP1 USP33	3.40e-05	321	208	13	GO:0031267
GeneOntologyMolecularFunction	deubiquitinase activity	USP20 ZUP1 USP44 USP15 USP49 PRPF8 USP26 USP33	4.75e-05	124	208	8	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP20 ZUP1 USP44 USP15 USP49 PRPF8 USP26 USP33	9.60e-05	137	208	8	GO:0019783
GeneOntologyMolecularFunction	GTPase binding	LRRK2 RTKN RPTOR RIN2 DIAPH3 RIC1 ANKFY1 ASB14 ASB15 APPL2 DEPDC5 TNFAIP1 USP33	1.09e-04	360	208	13	GO:0051020
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNHD1 DYNC2H1 DNAH1	1.92e-04	28	208	4	GO:0051959
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP20 ZUP1 USP44 USP15 USP49 USP26 USP33	1.93e-04	114	208	7	GO:0004843
GeneOntologyMolecularFunction	endothelin receptor activity	EDNRA EDNRB	3.22e-04	3	208	2	GO:0004962
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH14 DNHD1 DYNC2H1 DNAH1	5.77e-04	37	208	4	GO:0045505
GeneOntologyMolecularFunction	ATP-dependent activity	ATP8A2 DNAH14 MYO5C MDN1 ATP11B DNHD1 DYNC2H1 ANXA1 CHD9 ZNFX1 MSH5 ABCC6 NLRP3 DNAH1 ATAD3B ATP6V1H	7.34e-04	614	208	16	GO:0140657
MousePheno	head spot	EIF3CL KIT EDNRB EIF3C	3.29e-06	10	160	4	MP:0002939
Domain	ARM-type_fold	CAB39 SMG1 LRRK2 MIF4GD FOCAD RPTOR ATXN10 DIAPH3 GCN1 TARBP1 HSF2BP ZNFX1 APOB ARMCX3 KIFAP3 ATP6V1H NUP188 PUM1	3.99e-08	339	205	18	IPR016024
Domain	ZnF_UBP	USP20 USP44 USP49 USP33	4.38e-06	11	205	4	SM00290
Domain	Dynein_HC_stalk	DNAH14 DNHD1 DYNC2H1 DNAH1	1.29e-05	14	205	4	IPR024743
Domain	Znf_UBP	USP20 USP44 USP49 USP33	1.29e-05	14	205	4	IPR001607
Domain	zf-UBP	USP20 USP44 USP49 USP33	1.29e-05	14	205	4	PF02148
Domain	MT	DNAH14 DNHD1 DYNC2H1 DNAH1	1.29e-05	14	205	4	PF12777
Domain	ZF_UBP	USP20 USP44 USP49 USP33	1.29e-05	14	205	4	PS50271
Domain	DHC_fam	DNAH14 DNHD1 DYNC2H1 DNAH1	1.75e-05	15	205	4	IPR026983
Domain	Dynein_heavy	DNAH14 DNHD1 DYNC2H1 DNAH1	1.75e-05	15	205	4	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNHD1 DYNC2H1 DNAH1	1.75e-05	15	205	4	IPR004273
Domain	DUSP	USP20 USP15 USP33	2.54e-05	6	205	3	PF06337
Domain	DUSP	USP20 USP15 USP33	2.54e-05	6	205	3	SM00695
Domain	DUSP	USP20 USP15 USP33	4.42e-05	7	205	3	PS51283
Domain	-	USP20 USP15 USP33	4.42e-05	7	205	3	3.30.2230.10
Domain	Pept_C19_DUSP	USP20 USP15 USP33	4.42e-05	7	205	3	IPR006615
Domain	ARM-like	CAB39 SMG1 LRRK2 RPTOR ATXN10 GCN1 TARBP1 HSF2BP ARMCX3 KIFAP3 ATP6V1H PUM1	4.57e-05	270	205	12	IPR011989
Domain	USP_CS	USP20 USP44 USP15 USP49 USP26 USP33	8.54e-05	66	205	6	IPR018200
Domain	USP_1	USP20 USP44 USP15 USP49 USP26 USP33	1.19e-04	70	205	6	PS00972
Domain	EIF3C_N_dom	EIF3CL EIF3C	1.20e-04	2	205	2	IPR008905
Domain	eIF-3c_N	EIF3CL EIF3C	1.20e-04	2	205	2	PF05470
Domain	Endthln_rcpt	EDNRA EDNRB	1.20e-04	2	205	2	IPR000499
Domain	EIF3C	EIF3CL EIF3C	1.20e-04	2	205	2	IPR027516
Domain	UCH	USP20 USP44 USP15 USP49 USP26 USP33	1.29e-04	71	205	6	PF00443
Domain	USP_2	USP20 USP44 USP15 USP49 USP26 USP33	1.29e-04	71	205	6	PS00973
Domain	USP_3	USP20 USP44 USP15 USP49 USP26 USP33	1.39e-04	72	205	6	PS50235
Domain	USP_dom	USP20 USP44 USP15 USP49 USP26 USP33	1.39e-04	72	205	6	IPR028889
Domain	Peptidase_C19_UCH	USP20 USP44 USP15 USP49 USP26 USP33	1.39e-04	72	205	6	IPR001394
Domain	-	CAB39 LRRK2 RPTOR ATXN10 GCN1 HSF2BP ARMCX3 KIFAP3 ATP6V1H PUM1	1.77e-04	222	205	10	1.25.10.10
Domain	DUF4683	NEXMIF REV3L	3.57e-04	3	205	2	PF15735
Domain	DUF4683	NEXMIF REV3L	3.57e-04	3	205	2	IPR032757
Domain	-	TRPC3 TRPC6 LRRK2 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	4.29e-04	248	205	10	1.25.40.20
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DYNC2H1 DNAH1	4.34e-04	14	205	3	IPR024317
Domain	Dynein_heavy_dom-2	DNHD1 DYNC2H1 DNAH1	4.34e-04	14	205	3	IPR013602
Domain	DHC_N2	DNHD1 DYNC2H1 DNAH1	4.34e-04	14	205	3	PF08393
Domain	ATPase_dyneun-rel_AAA	MDN1 DYNC2H1 DNAH1	4.34e-04	14	205	3	IPR011704
Domain	AAA_8	DNAH14 DYNC2H1 DNAH1	4.34e-04	14	205	3	PF12780
Domain	AAA_5	MDN1 DYNC2H1 DNAH1	4.34e-04	14	205	3	PF07728
Domain	Ankyrin_rpt-contain_dom	TRPC3 TRPC6 LRRK2 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	5.17e-04	254	205	10	IPR020683
Domain	KRAB	ZNF568 ZNF264 ZNF484 ZNF805 ZFP28 ZNF880 ZNF677 ZNF100 ZNF253 ZNF470 ZNF528 ZNF669	6.21e-04	358	205	12	PS50805
Domain	KRAB	ZNF568 ZNF264 ZNF484 ZNF805 ZFP28 ZNF880 ZNF677 ZNF100 ZNF253 ZNF470 ZNF528 ZNF669	6.21e-04	358	205	12	PF01352
Domain	Ank_2	TRPC3 TRPC6 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	6.34e-04	215	205	9	PF12796
Domain	Ankyrin_rpt	TRPC3 TRPC6 LRRK2 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	6.57e-04	262	205	10	IPR002110
Domain	PLDc	PLD3 PLD1	7.09e-04	4	205	2	PF00614
Domain	KRAB	ZNF568 ZNF264 ZNF484 ZNF805 ZFP28 ZNF880 ZNF677 ZNF100 ZNF253 ZNF470 ZNF528 ZNF669	8.09e-04	369	205	12	SM00349
Domain	KRAB	ZNF568 ZNF264 ZNF484 ZNF805 ZFP28 ZNF880 ZNF677 ZNF100 ZNF253 ZNF470 ZNF528 ZNF669	8.28e-04	370	205	12	IPR001909
Domain	Ank	TRPC3 TRPC6 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	9.61e-04	228	205	9	PF00023
Domain	-	TDRD15 RNF17	1.75e-03	6	205	2	2.40.50.90
Domain	TRP_2	TRPC3 TRPC6	1.75e-03	6	205	2	PF08344
Domain	Staphylococal_nuclease_OB-fold	TDRD15 RNF17	1.75e-03	6	205	2	IPR016071
Domain	PLDc	PLD3 PLD1	1.75e-03	6	205	2	SM00155
Domain	TRP_dom	TRPC3 TRPC6	1.75e-03	6	205	2	IPR013555
Domain	ANK	TRPC3 TRPC6 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	1.87e-03	251	205	9	SM00248
Domain	ANK_REPEAT	TRPC3 TRPC6 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	1.97e-03	253	205	9	PS50088
Domain	ANK_REP_REGION	TRPC3 TRPC6 ANKFY1 UACA ASB14 ASB15 ANKRD55 ASB4 ANKRD7	2.03e-03	254	205	9	PS50297
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	RELN TRPM7 VPS26C LMO3 TUBGCP5 LRP1B FOCAD CSDE1 SACS ATXN10 TARBP1 VARS1 SOX6 CNTN4 OGT DSP SYNE1 CHD9 ZNFX1 ADAMTS8 REV3L PRPF8 FRY APPL2 RABEP1 ZNF528 EIF3C USP33	5.98e-09	1285	212	28	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STARD8 IP6K1 TUBGCP5 USP20 C2CD5 TTBK1 SACS RIC1 CNTN4 UACA DYNC2H1 ZFP28 ATAD3B VPS13D CMIP TTC21B PLCH1	1.17e-08	493	212	17	15368895
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	NEXMIF DNAH14 USP20 PRDM2 FOCAD ESRP2 MDN1 PCDH10 MXRA5 DSP REV3L PRPF8 FRY GTF3C1 TNFAIP1 NUP188 TNR TUBE1	7.20e-07	736	212	18	29676528
Pubmed	Increased gene expression of the cardiac endothelin system in obese mice.	ECE1 EDNRA EDNRB	8.89e-07	4	212	3	25181417
Pubmed	Pulsatile atheroprone shear stress affects the expression of transient receptor potential channels in human endothelial cells.	TRPM7 TRPC3 TRPC6	8.89e-07	4	212	3	22566504
Pubmed	Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene.	ECE1 EDNRA EDNRB	8.89e-07	4	212	3	9449665
Pubmed	Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects.	ECE1 EDNRA EDNRB	8.89e-07	4	212	3	16567585
Pubmed	Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans.	ECE1 EDNRA EDNRB	8.89e-07	4	212	3	16531800
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	USP20 USP44 GLDC KLHL42 USP15 GCN1 TARBP1 VARS1 USP49 ANKFY1 OGT DYNC2H1 ANXA1 KRR1 PRPF8 USP26 ATAD3B TNFAIP1 EIF3C NUP188 USP33	1.06e-06	1005	212	21	19615732
Pubmed	Hereditary Ataxia Overview	TRPC3 PLD3 SACS ATXN10 SYNE1 VPS13D PUM1	1.60e-06	92	212	7	20301317
Pubmed	Regulation of retinoblastoma gene expression in a mouse mammary tumor model.	ECE1 EDNRA EDNRB	2.21e-06	5	212	3	8548579
Pubmed	Endothelin in the central control of cardiovascular and respiratory functions.	ECE1 EDNRA EDNRB	2.21e-06	5	212	3	10626068
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	CAB39 PLD3 F13B ATXN10 GCN1 KRT9 KRT14 OGT KRT16 DSP ANXA1 VPS13D RABEP1 CNTNAP2 NUP188	2.27e-06	564	212	15	21565611
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	VPS26C USP20 ZUP1 C2CD5 USP15 UACA DEPDC5 USP33	3.60e-06	147	212	8	29576527
Pubmed	Humanized mice for investigating sustained Plasmodium vivax blood-stage infections and transmission.	C5 KIT RAG2	4.41e-06	6	212	3	35840625
Pubmed	Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion.	KRT14 KRT16 TNFRSF1A	4.41e-06	6	212	3	16702408
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO5C GCN1 KRT9 KRT14 UACA DSP ZNFX1 PRPF8 CNTNAP2	4.58e-06	202	212	9	33005030
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	IFT140 MIS18BP1 STARD8 PLD3 CHKA ELAC2 USP20 MDN1 GLDC GLE1 ATXN10 RNASEH2B MMS22L CHD9 KIFAP3 ZNF106 ATAD3B CMIP AKAP9 APPL2 TNFAIP1 USP33	8.28e-06	1242	212	22	30973865
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FOCAD CSDE1 FBXO28 USP15 PCDH10 ANKFY1 SYNE1 RSBN1 AKAP9 DZIP3 PUM1 USP33	8.61e-06	407	212	12	12693553
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	EFCAB5 CSDE1 C17orf75 MDN1 ATXN10 GCN1 VARS1 UACA DSP POLRMT CHD9 NAA50 PRPF8 CTSA KIFAP3 ATAD3B EIF3C	1.09e-05	809	212	17	32129710
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CAB39 SMG1 ATXN10 ZFAT ANKFY1 UACA DSP SYNE1 AKAP9 APPL2 RABEP1 EIF3C SMAD3	1.30e-05	497	212	13	23414517
Pubmed	Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.	ZUP1 KRT9 KRT14 KRT16 DSP PRPF8	1.31e-05	84	212	6	29563501
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	CAB39 LRRK2 PLD3 ACY1 C5 RHOF DNHD1 MXRA5 ANKFY1 UACA DSP DYNC2H1 ANXA1 NAA50 ECE1 CTSA VPS13D ATP6V1H APPL2	1.68e-05	1016	212	19	19056867
Pubmed	Venous endothelin guides sympathetic innervation of the developing mouse heart.	ECE1 EDNRA EDNRB	1.83e-05	9	212	3	24875861
Pubmed	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.	SMG1 EIF3CL ABCC6 GTF3C1 EIF3C PMFBP1	2.20e-05	92	212	6	10493829
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RGS22 PRDM2 EIF3CL MDN1 RPTOR ATXN10 GCN1 VARS1 DNHD1 ANKFY1 DSP DYNC2H1 SYNE1 POLRMT APOB KRR1 PRPF8 ATP6V1H GTF3C1 RBPJ EIF3C NUP188 PUM1	2.24e-05	1425	212	23	30948266
Pubmed	Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.	TRPC6 ECE1 EDNRA EDNRB RBPJ SMAD3	2.49e-05	94	212	6	20346360
Pubmed	The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.	TRPM7 TRPC3 TRPC6	2.60e-05	10	212	3	27177420
Pubmed	Heterogeneous distribution of TRPC proteins in the embryonic cortex.	RELN TRPC3 TRPC6	2.60e-05	10	212	3	18989690
Pubmed	mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.	EIF3CL RPTOR EIF3C	2.60e-05	10	212	3	16286006
Pubmed	The treasury of the commons: making use of public gene expression resources to better characterize the molecular diversity of inhibitory interneurons in the cerebellar cortex.	TRPC3 KIT CNTN4 OGT PLCH1 TNR	3.15e-05	98	212	6	19554387
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	LRP1B STAB2 EFCAB6 ANKRD55 ABCC6 FRY CNTNAP2 PLCH1	3.27e-05	199	212	8	23382691
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	TIPRL C2CD5 PRUNE1 PEX2 ATXN10 DIAPH3 GCN1 VARS1 OGT POLRMT PRPF8 ARMCX3 PTPN5 ATP6V1H GTF3C1 EIF3C NUP188 MAPK3	3.30e-05	974	212	18	28675297
Pubmed	Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response.	KIT RAG2 TNFRSF1A	3.55e-05	11	212	3	18768889
Pubmed	Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons.	ECE1 EDNRA EDNRB	3.55e-05	11	212	3	18401410
Pubmed	Lack of TNFRI signaling enhances annexin A1 biological activity in intestinal inflammation.	ANXA1 TNFRSF1A	3.70e-05	2	212	2	26386311
Pubmed	TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.	TRPC3 TRPC6	3.70e-05	2	212	2	22724068
Pubmed	NLRP3 inflammasome activation triggers gasdermin D-independent inflammation.	NLRP3 GSDMD	3.70e-05	2	212	2	34678046
Pubmed	Endothelin receptor heteromerization inhibits β-arrestin function in HEK293 cells.	EDNRA EDNRB	3.70e-05	2	212	2	32744876
Pubmed	Identification of a novel role for endothelins within the oviduct.	EDNRA EDNRB	3.70e-05	2	212	2	20357223
Pubmed	Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis.	KIT RAG2	3.70e-05	2	212	2	18981146
Pubmed	The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept.	NLRP3 TNFRSF1A	3.70e-05	2	212	2	28116820
Pubmed	Molecular cloning of the human homolog of a striatum-enriched phosphatase (STEP) gene and chromosomal mapping of the human and murine loci.	PTPN5 OTOG	3.70e-05	2	212	2	7490079
Pubmed	Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension.	EDNRA EDNRB	3.70e-05	2	212	2	24582810
Pubmed	Modulation of Transient Receptor Potential Channels 3 and 6 Regulates Osteoclast Function with Impact on Trabecular Bone Loss.	TRPC3 TRPC6	3.70e-05	2	212	2	32140760
Pubmed	Endothelin ETA and ETB receptor expression in the human trigeminal ganglion.	EDNRA EDNRB	3.70e-05	2	212	2	16816835
Pubmed	Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism.	EDNRA EDNRB	3.70e-05	2	212	2	11376172
Pubmed	ETA and ETB receptors are expressed in vascular adventitial fibroblasts.	EDNRA EDNRB	3.70e-05	2	212	2	21949113
Pubmed	Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.	EDNRA EDNRB	3.70e-05	2	212	2	19299580
Pubmed	Increased gene expression and production of murine endothelin receptors after birth.	EDNRA EDNRB	3.70e-05	2	212	2	12763050
Pubmed	Down-regulation of ETA receptors in ETB receptor-deficient mice.	EDNRA EDNRB	3.70e-05	2	212	2	15838300
Pubmed	Real-time polymerase chain reaction quantification of gene expression levels of murine endothelin-A and endothelin-B receptors: gene expression profiles by the standard curve method.	EDNRA EDNRB	3.70e-05	2	212	2	15838311
Pubmed	MicroRNA‑1929‑3p participates in murine cytomegalovirus‑induced hypertensive vascular remodeling through Ednra/NLRP3 inflammasome activation.	EDNRA NLRP3	3.70e-05	2	212	2	33416142
Pubmed	Endothelin receptor pharmacology and function in the mouse: comparison with rat and man.	EDNRA EDNRB	3.70e-05	2	212	2	15838332
Pubmed	Comparison of endothelin-A and endothelin-B receptor distribution visualized by radioligand binding versus immunocytochemical localization using subtype selective antisera.	EDNRA EDNRB	3.70e-05	2	212	2	15838285
Pubmed	Upregulation of vascular ET(B) receptor gene expression after chronic ET(A) receptor blockade in prediabetic NOD mice.	EDNRA EDNRB	3.70e-05	2	212	2	15838254
Pubmed	LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2-GSDMD Axis-Mediated Gut Inflammation.	LRRK2 GSDMD	3.70e-05	2	212	2	38607004
Pubmed	Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice.	EDNRA EDNRB	3.70e-05	2	212	2	24756152
Pubmed	O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyroptosis.	OGT GSDMD	3.70e-05	2	212	2	37962578
Pubmed	DHA induces Jurkat T-cell arrest in G2/M phase of cell cycle and modulates the plasma membrane expression of TRPC3/6 channels.	TRPC3 TRPC6	3.70e-05	2	212	2	33333171
Pubmed	Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.	EDNRA EDNRB	3.70e-05	2	212	2	12875994
Pubmed	Associations of EDNRA and EDNRB Polymorphisms with Intracerebral Hemorrhage.	EDNRA EDNRB	3.70e-05	2	212	2	31150867
Pubmed	Expression and significance of effector proteins NLRP3 and gasdermin D N-terminal protein in the pyrolysis pathway in breast cancer.	NLRP3 GSDMD	3.70e-05	2	212	2	37800794
Pubmed	Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease.	C5 KIT	3.70e-05	2	212	2	23071133
Pubmed	Upregulation and Diverse Roles of TRPC3 and TRPC6 in Synaptic Reorganization of the Mossy Fiber Pathway in Temporal Lobe Epilepsy.	TRPC3 TRPC6	3.70e-05	2	212	2	25213992
Pubmed	Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention.	EDNRA EDNRB	3.70e-05	2	212	2	18784261
Pubmed	Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries.	EDNRA EDNRB	3.70e-05	2	212	2	14729387
Pubmed	TRPC3 participates in angiotensin II type 1 receptor-dependent stress-induced slow increase in intracellular Ca2+ concentration in mouse cardiomyocytes.	TRPC3 TRPC6	3.70e-05	2	212	2	28105583
Pubmed	Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia.	TRPM7 ANXA1	3.70e-05	2	212	2	19103997
Pubmed	Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites.	TRPC3 TRPC6	3.70e-05	2	212	2	35051376
Pubmed	Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade.	EDNRA EDNRB	3.70e-05	2	212	2	16399858
Pubmed	Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein.	TRPC3 TRPC6	3.70e-05	2	212	2	9368034
Pubmed	Role of endothelin-1 and its receptors, ETA and ETB, in the survival of human vascular endothelial cells.	EDNRA EDNRB	3.70e-05	2	212	2	28732172
Pubmed	Ovarian hormones modulate endothelin-1 receptor responses in young women.	EDNRA EDNRB	3.70e-05	2	212	2	29999581
Pubmed	Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.	FBXO39 RNF17	3.70e-05	2	212	2	24377578
Pubmed	Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis.	LRRK2 GSDMD	3.70e-05	2	212	2	35907404
Pubmed	Expression of endothelin receptors in frog, chicken, mouse and human pigment cells.	EDNRA EDNRB	3.70e-05	2	212	2	16962346
Pubmed	The expression of endothelin type A and B receptors in the lateral wall of the mouse cochlea.	EDNRA EDNRB	3.70e-05	2	212	2	17607529
Pubmed	Annexin A1 Regulates NLRP3 Inflammasome Activation and Modifies Lipid Release Profile in Isolated Peritoneal Macrophages.	ANXA1 NLRP3	3.70e-05	2	212	2	32283822
Pubmed	The functional diversity of epidermal keratins revealed by the partial rescue of the keratin 14 null phenotype by keratin 16.	KRT14 KRT16	3.70e-05	2	212	2	10477769
Pubmed	Expression of endothelin receptor subtypes in bronchial tumors.	EDNRA EDNRB	3.70e-05	2	212	2	20043107
Pubmed	[Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].	TRPC3 TRPC6	3.70e-05	2	212	2	20190513
Pubmed	Functional diversity of endothelin pathways in human lung fibroblasts may be based on structural diversity of the endothelin receptors.	EDNRA EDNRB	3.70e-05	2	212	2	14636059
Pubmed	EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.	EIF3CL EIF3C	3.70e-05	2	212	2	36157221
Pubmed	Role of Annexin A1 in NLRP3 Inflammasome Activation in Murine Neutrophils.	ANXA1 NLRP3	3.70e-05	2	212	2	33440601
Pubmed	Molecular characterization and regulation of the human endothelin receptors.	EDNRA EDNRB	3.70e-05	2	212	2	8440682
Pubmed	Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension.	EDNRA EDNRB	3.70e-05	2	212	2	22688668
Pubmed	Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.	CHKA PLD1	3.70e-05	2	212	2	24556997
Pubmed	Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection.	NLRP3 GSDMD	3.70e-05	2	212	2	36828815
Pubmed	Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice.	EDNRA EDNRB	3.70e-05	2	212	2	10198387
Pubmed	[Molecular cloning of human endothelin receptors and their expression in vascular endothelial cells and smooth muscle cells].	EDNRA EDNRB	3.70e-05	2	212	2	1291713
Pubmed	Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice.	EDNRA EDNRB	3.70e-05	2	212	2	22365955
Pubmed	Paternal USP26 mutations raise Klinefelter syndrome risk in the offspring of mice and humans.	TEX11 USP26	3.70e-05	2	212	2	33978233
Pubmed	Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.	RAG2 SMAD3	3.70e-05	2	212	2	19119184
Pubmed	Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.	RPTOR CTSK	3.70e-05	2	212	2	27879318
Pubmed	N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity.	TRPC3 TRPC6	3.70e-05	2	212	2	12970363
Pubmed	cDNA cloning, expression, and assembly characteristics of mouse keratin 16.	KRT14 KRT16	3.70e-05	2	212	2	9822705
Pubmed	Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins.	USP20 USP33	3.70e-05	2	212	2	33792613
Pubmed	Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol.	TRPC3 TRPC6	3.70e-05	2	212	2	9930701
Pubmed	Facial hyperalgesia due to direct action of endothelin-1 in the trigeminal ganglion of mice.	EDNRA EDNRB	3.70e-05	2	212	2	29570803
Interaction	SYNC interactions	TUBGCP5 KLHL42 CCDC136 KRT14 KRT16 UACA RABEP1	5.45e-06	67	206	7	int:SYNC
Interaction	ZUP1 interactions	VPS26C ZUP1 C2CD5 KRT9 KRT14 KRT16 UACA DSP PRPF8 DEPDC5	1.26e-05	174	206	10	int:ZUP1
Interaction	KRT8 interactions	SMG1 HAUS4 DIAPH3 KRT14 OGT KRT16 ZNF484 UACA DSP ANXA1 PRPF8 AKAP9 RABEP1 NUP188 MAPK3 PUM1	1.31e-05	441	206	16	int:KRT8
Interaction	C3orf18 interactions	SMG1 IP6K1 MDN1 SACS KLHL42 DIAPH3 TARBP1 DYNC2H1	2.41e-05	115	206	8	int:C3orf18
GeneFamily	Ubiquitin specific peptidases	USP20 USP44 USP15 USP49 USP26 USP33	6.06e-06	56	147	6	366
GeneFamily	Endothelin receptors	EDNRA EDNRB	6.57e-05	2	147	2	225
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF568 ZUP1 ZNF264 ZFAT ZNF484 ZNF805 ZFP28 ZNF880 ZNF677 ZNF106 ZNF100 ZNF253 ZNF470 ZNF528 ZNF669	7.63e-04	718	147	15	28
GeneFamily	Transient receptor potential cation channels	TRPM7 TRPC3 TRPC6	1.49e-03	28	147	3	249
GeneFamily	Keratins, type I	KRT9 KRT14 KRT16	1.49e-03	28	147	3	608
GeneFamily	Adenosine deaminases acting on RNA	ADAT2 ADAT1	1.78e-03	8	147	2	1303
Coexpression	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	LMO3 HMGCS1 MYO5C TXK DIAPH3 USP15 KRT14 POLRMT ECE1 SERPINA6 MX2	6.01e-07	198	209	11	M5571
Coexpression	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	ZDHHC2 SMG1 GALNT7 USP44 RNASEH2B ZNF880 ATP6V1H DZIP3 ZNF528 PUM1	4.83e-06	199	209	10	M9238
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	IP6K1 ACY1 ESRP2 RHOF HIPK2 ZFP28 VPS13D GSDMD RBPJ MX2	5.05e-06	200	209	10	M6035
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA2	ATP8A2 LMO3 LRFN5 SOX6 USP49 CNTN4 ZNFX1 REV3L RNF17 PTPN5 KIFAP3 FRY CMIP CNTNAP2 ASB4	1.74e-05	513	209	15	M39069
Coexpression	AKL_HTLV1_INFECTION_DN	ATP8A2 ANXA1 REV3L CTSA FRY AKAP9	1.89e-05	69	209	6	M9815
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	SMG1 TRPM7 NEXMIF NR6A1 PLD3 CHKA GALNT7 ZUP1 FOCAD ATP11B SACS CNTN4 ANKFY1 HSF2BP CHD9 TEX11 ECE1 RNF17 EDNRA ATP6V1H APPL2 DZIP3 DEPDC5 PUM1	9.66e-07	795	207	24	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	SMG1 CHKA RPTOR GCN1 OGT HIPK2 REV3L EDNRA EDNRB RSBN1 AKAP9 APPL2 ASB4 PUM1 TUBE1	6.10e-06	385	207	15	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN RGS22 LRP1B PCDH10 STAB2 EFCAB6 APOB TEX11 DNAH1 PLCH1 OTOG	1.45e-09	184	212	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN RGS22 LRP1B PCDH10 STAB2 EFCAB6 APOB TEX11 DNAH1 PLCH1 OTOG	1.45e-09	184	212	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN RGS22 LRP1B PCDH10 STAB2 EFCAB6 APOB TEX11 DNAH1 PLCH1 OTOG	1.45e-09	184	212	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PXDNL CNTN4 CACNA1D COL6A6 DYNC2H1 SYNE1 ADAMTS8 REV3L EDNRA AKAP9 GTF3C1	3.49e-09	200	212	11	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC2 RTKN HAUS4 DIAPH3 USP49 HSF2BP PTPN5 TUBE1 CTSK SMAD3	2.04e-08	184	212	10	b998803180322a5ea2b567928dea531c26816c3c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 FOCAD LRFN5 TARBP1 CNTN4 CACNA1D SYNE1 KIFAP3 FRY CNTNAP2	3.72e-08	196	212	10	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 FOCAD LRFN5 TARBP1 CNTN4 CACNA1D SYNE1 KIFAP3 FRY CNTNAP2	4.09e-08	198	212	10	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 FOCAD LRFN5 TARBP1 CNTN4 CACNA1D SYNE1 KIFAP3 FRY CNTNAP2	4.09e-08	198	212	10	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	ATP8A2 FOCAD LRFN5 TARBP1 CNTN4 CACNA1D SYNE1 KIFAP3 FRY CNTNAP2	4.50e-08	200	212	10	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	ACY1 C2CD5 CACNA1D OGT DYNC2H1 SYNE1 CHD9 CMTR2	2.82e-07	135	212	8	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 LMO3 NR6A1 DNAH14 TTC6 MYO5C MTUS1 CNTN4 ABCC6	2.84e-07	186	212	9	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LRRK2 LMO3 TTC6 CNTN6 MYO5C DSP ABCC6 FRY PLCH1	3.10e-07	188	212	9	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 CNTN4 ABCC6 PLCH1	3.71e-07	192	212	9	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 CNTN4 ABCC6 PLCH1	3.71e-07	192	212	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 LMO3 CHKA DNAH14 TTC6 MYO5C MTUS1 ABCC6 PLCH1	3.87e-07	193	212	9	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LMO3 TTC6 CNTN6 MYO5C ESRP2 C5 DSP FRY PLCH1	4.22e-07	195	212	9	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 FOCAD LRFN5 CNTN4 CACNA1D SYNE1 KIFAP3 FRY CNTNAP2	4.80e-07	198	212	9	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PXDNL CNTN4 CACNA1D COL6A6 DYNC2H1 SYNE1 ADAMTS8 REV3L EDNRA	5.01e-07	199	212	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC6 RIN2 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	5.22e-07	200	212	9	347a510755374c6a66acee326565dfc447993f18
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LMO3 HMGCS1 NR6A1 TTC6 MYO5C USP44 MTUS1 CNTN4	2.10e-06	176	212	8	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LMO3 NR6A1 TTC6 CNTN6 MYO5C USP44 MTUS1 CNTN4	2.38e-06	179	212	8	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN MTUS1 CTHRC1 STAB2 UACA DSP EDNRB FRY	2.38e-06	179	212	8	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TTC6 MYO5C TXK ESRP2 GLDC C5 FRY PLCH1	2.92e-06	184	212	8	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	C2CD5 FOCAD C17orf75 FBXO28 KLHL42 ATP6V1H CMTR2 ADAT2	3.04e-06	185	212	8	e06a784a297f357f3f8e761c24fa70722048ab42
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 LMO3 NR6A1 TTC6 MYO5C USP44 MTUS1 CNTN4	3.04e-06	185	212	8	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	NEXMIF LMO3 TTC6 MYO5C MTUS1 CNTN4 DSP PLCH1	3.04e-06	185	212	8	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	LRRK2 LMO3 NR6A1 TTC6 MYO5C USP44 MTUS1 CNTN4	3.30e-06	187	212	8	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IFT140 FZD4 RIN2 UACA SYNE1 EDNRB FRY TNR	3.57e-06	189	212	8	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LMO3 TTC6 MYO5C ESRP2 DSP ABCC6 FRY PLCH1	3.71e-06	190	212	8	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 CNTN4 PLCH1	3.86e-06	191	212	8	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 ABCC6 PLCH1	3.86e-06	191	212	8	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	3.86e-06	191	212	8	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 ABCC6 PLCH1	3.86e-06	191	212	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 LMO3 HMGCS1 DNAH14 MYO5C MTUS1 CNTN4 PLCH1	4.01e-06	192	212	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	LRRK2 LMO3 HMGCS1 DNAH14 MYO5C MTUS1 CNTN4 PLCH1	4.01e-06	192	212	8	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	4.01e-06	192	212	8	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	4.16e-06	193	212	8	010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	4.16e-06	193	212	8	2189da4b727e25e62669d7b9257f06493be21a27
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	4.16e-06	193	212	8	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LMO3 TTC6 CNTN6 MYO5C USP44 DSP FRY PLCH1	4.16e-06	193	212	8	b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 GPR82 TUBGCP5 TXK OGT SYNE1 TEX11 AKAP9	4.16e-06	193	212	8	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5C KIT EFCAB6 UACA DSP ANKRD55 EDNRB	4.49e-06	138	212	7	5f8ac8f67e34a7cf560099208e6884102532391e
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 LMO3 NR6A1 DNAH14 MYO5C MTUS1 SYNE1 PLCH1	4.49e-06	195	212	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	LRRK2 MTUS1 PXDNL COL6A6 DYNC2H1 SYNE1 CHD9 AKAP9	4.84e-06	197	212	8	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	LRRK2 TTC6 MYO5C MTUS1 C5 SOX6 DSP AKAP9	4.84e-06	197	212	8	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LRRK2 TTC6 MYO5C USP44 MTUS1 C5 DSP AKAP9	5.03e-06	198	212	8	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 LMO3 HMGCS1 NR6A1 MYO5C USP44 MTUS1 PLCH1	5.03e-06	198	212	8	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 LRFN5 TARBP1 CNTN4 CACNA1D KIFAP3 FRY CNTNAP2	5.03e-06	198	212	8	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LMO3 NR6A1 CHKA DNAH14 TTC6 MYO5C MTUS1 PLCH1	5.22e-06	199	212	8	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LMO3 NR6A1 CHKA DNAH14 TTC6 MYO5C MTUS1 PLCH1	5.22e-06	199	212	8	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	LRRK2 LMO3 TTC6 MYO5C MTUS1 C5 DSP AKAP9	5.41e-06	200	212	8	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	5.41e-06	200	212	8	858421b91f5207b7934b5c219752cb9322a3da31
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	5.41e-06	200	212	8	a7022762c1d8aedb7b3e9605873b1e68b9907b35
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC6 CCDC136 SOX6 ANKRD55 EDNRA CNTNAP2 PLCH1	5.41e-06	200	212	8	2131c8e7fa054b79906eaf60536da892438b09cd
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NEXMIF TRPC6 HMGCS1 KIT HTR7 REV3L ZNF669	1.00e-05	156	212	7	0f2147abcf31a26ee5b2f4d8c5d72232612a33f0
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NEXMIF TRPC6 HMGCS1 KIT HTR7 REV3L ZNF669	1.00e-05	156	212	7	cb87f12443fdc5538b856f765fcbac9406044e10
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3\|TCGA-Skin / Sample_Type by Project: Shred V9	NR6A1 PEX2 SOX6 USP49 REV3L EDNRB ZNF106	1.14e-05	159	212	7	fb222c42f66901852b01cec073ec0732245ee973
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MTUS1 ABCC6 ASB4	1.14e-05	159	212	7	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN TXK EFCAB6 EDNRB PTPN5 ADAT1 MX2	1.14e-05	159	212	7	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN TXK EFCAB6 EDNRB PTPN5 ADAT1 MX2	1.14e-05	159	212	7	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	LRP1B MDN1 SYNE1 HIPK2 VPS13D DZIP3 TNR	2.27e-05	177	212	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 DIAPH3 CNTN4 KRT14 COL6A6 ADAT2 ANKRD7	2.27e-05	177	212	7	4197cf2b1e743230c821f422836fa5991b155a52
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN6 MYO5C RHOF SOX6 DSP ANXA1 MX2	2.36e-05	178	212	7	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FZD4 KRT14 KRT16 APOB RNF17 EDNRA CTSK	2.36e-05	178	212	7	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FZD4 KRT14 KRT16 APOB RNF17 EDNRA CTSK	2.36e-05	178	212	7	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 LMO3 CHKA MYO5C MTUS1 C5 PLCH1	2.44e-05	179	212	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEXMIF ATP8A2 SOX6 MXRA5 DYNC2H1 EDNRB FRY	2.44e-05	179	212	7	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	mild-B_cell\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STARD8 CHKA ELAC2 METTL16 ZFAT MSH5 ZNF253	2.81e-05	183	212	7	175aaf8fbbff52eab87d78a49d5ab02cd489c438
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 LMO3 CHKA MYO5C MTUS1 C5 PLCH1	2.81e-05	183	212	7	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	LRRK2 LMO3 HMGCS1 TTC6 MYO5C MTUS1 PLCH1	2.91e-05	184	212	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	RGS22 LRFN5 KIT CNTN4 REV3L EDNRB ZNF106	2.91e-05	184	212	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 LMO3 MYO5C MTUS1 C5 SOX6 PLCH1	3.02e-05	185	212	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LMO3 CNTN6 MYO5C C5 SOX6 DSP ANXA1	3.02e-05	185	212	7	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RELN GLDC CACNA1D ABCC6 CMIP PUM1 SMAD3	3.02e-05	185	212	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LMO3 NR6A1 CHKA CNTN6 MYO5C MTUS1 C5	3.12e-05	186	212	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 LMO3 CHKA MYO5C MTUS1 C5 PLCH1	3.12e-05	186	212	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TRPC6 CTHRC1 SOX6 KRT9 ZNF484	3.14e-05	126	212	6	94bd9cfe982b41a3114885173eab55feb0fbbbae
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LMO3 CHKA CNTN6 MYO5C MTUS1 C5 DSP	3.23e-05	187	212	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN NEXMIF ATP8A2 TRPC3 RTKN STAB2 ECE1	3.34e-05	188	212	7	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 LMO3 CHKA MYO5C MTUS1 C5 PLCH1	3.34e-05	188	212	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN NEXMIF ATP8A2 TRPC3 RTKN STAB2 ECE1	3.34e-05	188	212	7	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	LRRK2 HMGCS1 DNAH14 MTUS1 C5 CACNA1D PLCH1	3.34e-05	188	212	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LMO3 TTC6 CNTN6 MYO5C DSP FRY PLCH1	3.34e-05	188	212	7	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LMO3 CHKA CNTN6 MYO5C MTUS1 C5 DSP	3.34e-05	188	212	7	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	LRRK2 LMO3 NR6A1 DNAH14 MYO5C MTUS1 PLCH1	3.34e-05	188	212	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LMO3 CNTN6 MYO5C MTUS1 C5 KRT16 ANXA1	3.46e-05	189	212	7	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM7 NR6A1 LRP1B MYO5C SOX6 CACNA1D DYNC2H1	3.46e-05	189	212	7	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO5C USP44 ESRP2 GLDC DIAPH3 DSP ABCC6	3.46e-05	189	212	7	a6c62b456982067ad4d224a2efa3919969000693
ToppCell	IPF-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	LRRK2 USP44 ECE1 NLRP3 OSM MX2 SMAD3	3.46e-05	189	212	7	ad7bb3a7de8e48c145e4382f90d30bb2159c2b76
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 CHKA TTC6 MYO5C C5 FRY PLCH1	3.58e-05	190	212	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRK2 LMO3 TTC6 MYO5C MTUS1 ABCC6 PLCH1	3.58e-05	190	212	7	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 DNAH14 TTC6 MTUS1 C5 SOX6 PLCH1	3.70e-05	191	212	7	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF CHKA MYO5C ESRP2 DSP TEX11 C6orf132	3.70e-05	191	212	7	c06bbad24e4897b2c3b5015e4de02411ebf75367
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	TRPC6 CACNA1D MXRA5 COL6A6 UACA ADAMTS8 EDNRA	3.70e-05	191	212	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ATP8A2 C17orf75 RHOF HTR7 HAP1 PTPN5 CNTNAP2	3.70e-05	191	212	7	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ATP8A2 C17orf75 RHOF HTR7 HAP1 PTPN5 CNTNAP2	3.70e-05	191	212	7	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC6 LRFN5 CACNA1D COL6A6 UACA ADAMTS8 EDNRA	3.70e-05	191	212	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	facs-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF CHKA MYO5C ESRP2 DSP TEX11 C6orf132	3.70e-05	191	212	7	5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	LRRK2 LMO3 DNAH14 TTC6 MYO5C MTUS1 CNTN4	3.70e-05	191	212	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	TRPC6 CACNA1D MXRA5 COL6A6 UACA ADAMTS8 EDNRA	3.70e-05	191	212	7	1726add3f392a061536b7aff72ba84303f4a0b1f
Drug	LOE 908	TRPM7 HTR7 EDNRA EDNRB MAPK3	4.83e-07	18	209	5	CID000122081
Drug	phosphoramidon	ECE1 EDNRA EDNRB MAPK3	1.15e-05	16	209	4	ctd:C008890
Drug	phenyl isocyanate	KRT9 KRT14 KRT16	1.49e-05	6	209	3	ctd:C025319
Drug	SKF-7261	RAG2 KRT14 KRT16 TNFAIP1 TNFRSF1A	2.44e-05	38	209	5	CID000015773
Drug	19-oxo-11-deoxycorticosterone acetate	EDNRA EDNRB MAPK3	2.60e-05	7	209	3	ctd:C040168
Drug	clazosentan	EDNRA EDNRB TNFRSF1A	4.13e-05	8	209	3	CID006433095
Drug	AC1L1JVU	TRPM7 TRPC6 CACNA1D NAA50 EDNRA MAPK3	5.25e-05	72	209	6	CID000005229
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	PRDM2 MTUS1 ZNF264 ANKFY1 HIPK2 RABEP1 CNTNAP2 PCNX1 TNFAIP1	7.11e-05	191	209	9	4273_DN
Drug	Magnetite Nanoparticles	ZDHHC2 SMG1 TRPM7 GPR84 HMGCS1 PLD3 CHKA ACY1 GALNT7 ZUP1 PRDM2 ALKBH8 SACS KIT RHOF CHD9 MSH5 NAA50 REV3L KRR1 NLRP3 AKAP9 ZNF253 DZIP3 TNFRSF1A CTSK ADAT1	7.13e-05	1310	209	27	ctd:D058185
Drug	Furoxanobenzofuroxan	GNPAT ECE1 EDNRA EDNRB PUM1	7.72e-05	48	209	5	CID000313608
Drug	AC1L9K72	ATP8A2 PLD3 CHKA ACY1 PEX2 PLD1 ANXA1 APOB CTSA ABCC6 PLCH1	8.14e-05	290	209	11	CID000446872
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	STARD8 TRPC3 LMO3 NR6A1 MTUS1 PGLYRP4 NLRP3 CNTNAP2 INO80B	8.33e-05	195	209	9	3669_UP
Drug	Bosentan	EDNRA EDNRB	8.39e-05	2	209	2	DB00559
Drug	TAK 044	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C088196
Drug	6-bromo-2,3-dihydrobenzofuran	EDNRA EDNRB	8.39e-05	2	209	2	CID011252616
Drug	Ultravate	ANXA1 SERPINA6	8.39e-05	2	209	2	CID000048175
Drug	1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C087551
Drug	IRL 1620	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C074308
Drug	enrasentan	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C098288
Drug	PD 145065	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C082887
Drug	LU 224332	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C113044
Drug	Sitaxentan	EDNRA EDNRB	8.39e-05	2	209	2	DB06268
Drug	A 182086	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C467893
Drug	PD 156252	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C106950
Drug	L-671,776	EDNRA EDNRB	8.39e-05	2	209	2	CID000122853
Drug	tezosentan	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C120582
Drug	spirodihydrobenzofuranlactam VI	EDNRA EDNRB	8.39e-05	2	209	2	CID000469820
Drug	J 104132	EDNRA EDNRB	8.39e-05	2	209	2	ctd:C119319
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A	NR6A1 FBXL18 METTL16 CACNA1D EFCAB6 HAP1 EDNRA OR1D2 PLCH1	8.67e-05	196	209	9	3827_UP
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	METTL16 KRT9 STAB2 HIPK2 OR1D2 CNTNAP2 NUP188 PLCH1 ANKRD7	8.67e-05	196	209	9	4739_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A	STARD8 PRDM2 PLD1 METTL16 EFCAB6 ABCC6 EDNRB OR1D2 ZNF528	8.67e-05	196	209	9	4524_UP
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	METTL16 HIPK2 ECE1 VPS13D APPL2 DZIP3 MAPK3 SMAD3 PMFBP1	9.01e-05	197	209	9	2970_DN
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A	VPS26C PLD3 PRUNE1 GLE1 C5 ANXA1 RABEP1 TNFAIP1 SMAD3	9.01e-05	197	209	9	7101_DN
Drug	Boldine [476-70-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	PLD3 TXK ANKFY1 HSF2BP ECE1 CNTNAP2 PCNX1 ZNF528 INO80B	9.37e-05	198	209	9	4004_DN
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A	C17orf75 ATP11B ZNF264 PLD1 TARBP1 MED6 KRR1 KIFAP3 VPS13D	9.37e-05	198	209	9	1907_UP
Drug	valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A	TRPC3 CACNA1D FRY TTC21B PCNX1 ZNF528 NUP188 PLCH1 INO80B	9.37e-05	198	209	9	6378_DN
Drug	Folic acid [59-30-3]; Up 200; 9uM; HL60; HG-U133A	CHKA PRDM2 DYNC2H1 HIPK2 OR1D2 PCNX1 TNR ZNF669 SMAD3	9.73e-05	199	209	9	1790_UP
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CDK16 VPS26C TIPRL CHKA DYNC2H1 ECE1 VPS13D RABEP1 PLCH1	9.73e-05	199	209	9	3403_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	HMGCS1 TUBGCP5 PRDM2 FZD4 MDN1 METTL16 ANKFY1 KIFAP3 DZIP3	9.73e-05	199	209	9	5321_DN
Drug	ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A	IFT140 RIN2 PLD1 METTL16 MED6 HTR7 VPS13D RABEP1 PLCH1	1.01e-04	200	209	9	2665_DN
Drug	Succimer	ZDHHC2 SMG1 TRPM7 GPR84 HMGCS1 PLD3 CHKA ACY1 GALNT7 ZUP1 PRDM2 ALKBH8 SACS KIT RHOF CHD9 MSH5 NAA50 REV3L KRR1 NLRP3 AKAP9 ZNF253 DZIP3 CTSK ADAT1	1.01e-04	1264	209	26	ctd:D004113
Drug	benidipine	ECE1 EDNRA EDNRB MAPK3	1.03e-04	27	209	4	ctd:C061004
Disease	common carotid intimal medial thickness	TDRD15 ATP8A2 DLEC1 MMS22L APOB CNTNAP2	7.33e-06	67	205	6	EFO_0004860
Disease	von Willebrand factor measurement, coronary artery disease	TDRD15 STAB2 DYNC2H1 APOB EDNRA SMAD3 PMFBP1	1.94e-05	118	205	7	EFO_0001645, EFO_0004629
Disease	Charlevoix-Saguenay spastic ataxia (implicated_via_orthology)	SACS ANKFY1	4.80e-05	2	205	2	DOID:0050946 (implicated_via_orthology)
Disease	Jeune thoracic dystrophy	IFT140 DYNC2H1 TTC21B	5.23e-05	11	205	3	C0265275
Disease	Short Rib-Polydactyly Syndrome	IFT140 DYNC2H1 TTC21B	8.98e-05	13	205	3	C0036996
Disease	Saldino-Noonan Syndrome	IFT140 DYNC2H1 TTC21B	1.14e-04	14	205	3	C0036069
Disease	Majewski Syndrome	IFT140 DYNC2H1 TTC21B	1.14e-04	14	205	3	C0024507
Disease	visceral:subcutaneous adipose tissue ratio	ELAC2 CNTN6 CACNA1D ZFAT CNTNAP2	1.29e-04	70	205	5	EFO_0004767
Disease	factor VIII measurement, coronary artery disease	TDRD15 STAB2 DYNC2H1 APOB EDNRA SMAD3	1.42e-04	113	205	6	EFO_0001645, EFO_0004630
Disease	Epidermolytic palmoplantar keratoderma Vorner type	KRT9 KRT16	1.43e-04	3	205	2	C2931735
Disease	complement C5 measurement	F13B C5	1.43e-04	3	205	2	EFO_0020278
Disease	Epidermolytic palmoplantar keratoderma of Vorner	KRT9 KRT16	1.43e-04	3	205	2	C0343110
Disease	Keratoderma, Palmoplantar, Epidermolytic	KRT9 KRT16	1.43e-04	3	205	2	C1721006
Disease	Autosomal Dominant Lateral Temporal Lobe Epilepsy	RELN DEPDC5	1.43e-04	3	205	2	C1838062
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	2.86e-04	4	205	2	cv:C0265275
Disease	childhood aggressive behaviour measurement	DLEC1 CNTN4 TTC21B ASB4 ANKRD7	3.99e-04	89	205	5	EFO_0007663
Disease	proprotein convertase subtilisin/kexin type 9 measurement	TDRD15 APOB ZNF528	4.62e-04	22	205	3	EFO_0009312
Disease	QRS duration, response to sulfonylurea	MDN1 LRFN5 LRRC63	5.28e-04	23	205	3	EFO_0005055, EFO_0007922
Disease	nephrotic syndrome (biomarker_via_orthology)	APOB ECE1 EDNRA	6.01e-04	24	205	3	DOID:1184 (biomarker_via_orthology)
Disease	coronary artery disease	TDRD15 IFT140 TRPM7 RPTOR DLEC1 C5 RHOF SOX6 DYNC2H1 HSF2BP APOB ANKRD55 EDNRA RSBN1 OSM CMIP ZNF100 SMAD3 PMFBP1	7.07e-04	1194	205	19	EFO_0001645
Disease	Aganglionic megacolon	ECE1 EDNRB	7.07e-04	6	205	2	cv:C0019569
Disease	DNA methylation	LRP1B CNTN6 MDN1 PXDNL LRFN5 PCDH10 DNHD1 CNTN4 ZFAT FRY CNTNAP2 TNR PMFBP1	7.24e-04	656	205	13	GO_0006306
Disease	fibrinogen measurement, coronary artery disease	TDRD15 DYNC2H1 CHD9 EDNRA NLRP3 SMAD3	7.48e-04	154	205	6	EFO_0001645, EFO_0004623
Disease	mean arterial pressure	IP6K1 TTBK1 PXDNL RPTOR SOX6 CACNA1D MMS22L TFAP2D HIPK2 ASB15 CMIP	7.87e-04	499	205	11	EFO_0006340
Disease	Craniofacial Abnormalities	FZD4 CNTN4 ANXA1 ECE1 EDNRA SMAD3	8.00e-04	156	205	6	C0376634
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	RGS22 C5 ANKRD55 RSBN1	9.78e-04	63	205	4	EFO_0000685, EFO_0007791, EFO_0009459
Disease	Hereditary Autoinflammatory Diseases	NLRP3 TNFRSF1A	9.86e-04	7	205	2	C0751422
Disease	pulmonary hypertension (is_marker_for)	TRPC3 TRPC6 EDNRA EDNRB	1.04e-03	64	205	4	DOID:6432 (is_marker_for)
Disease	coronary artery disease, factor VII measurement	TDRD15 DYNC2H1 APOB EDNRA SMAD3	1.09e-03	111	205	5	EFO_0001645, EFO_0004619
Disease	serum IgG glycosylation measurement	LRP1B ALKBH8 USP15 STAB2 EFCAB6 NAA50 ANKRD55 ABCC6 FRY CNTNAP2 PLCH1	1.15e-03	523	205	11	EFO_0005193
Disease	Intellectual Disability	CDK16 ATP8A2 ACY1 CSDE1 ALKBH8 SACS RNASEH2B SYNE1 FRY PUM1	1.21e-03	447	205	10	C3714756
Disease	carotid artery intima media thickness	TDRD15 LRRK2 LRP1B DLEC1 METTL16 UACA DYNC2H1 APOB EDNRA CNTNAP2	1.28e-03	450	205	10	EFO_0007117
Disease	Hirschsprung Disease	RELN ECE1 EDNRB	1.29e-03	31	205	3	C0019569
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 APOB	1.31e-03	8	205	2	EFO_0008589, EFO_0008595
Disease	intelligence, specific language impairment, dyslexia	CCDC136 PMFBP1	1.31e-03	8	205	2	EFO_0004337, EFO_0005424, EFO_1001510
Disease	autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis	LRRK2 ANKRD55 RSBN1 SMAD3	1.45e-03	70	205	4	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517
Disease	age at onset, coronary stenosis	DLEC1 PLD1	1.67e-03	9	205	2	EFO_0004847, MONDO_0006715
Disease	Vasodilators used in cardiac diseases use measurement	DYNC2H1 APOB EDNRA	1.69e-03	34	205	3	EFO_0009926
Disease	pack-years measurement, systolic blood pressure	LRP1B CNTN4 FRY	1.69e-03	34	205	3	EFO_0006335, EFO_0006526
Disease	Autoinflammatory disorder	RNASEH2B NLRP3 TNFRSF1A	1.84e-03	35	205	3	C3860213
Disease	Sarcomatoid Renal Cell Carcinoma	LRRK2 ACY1 LRP1B DNHD1 ASB15	2.04e-03	128	205	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	LRRK2 ACY1 LRP1B DNHD1 ASB15	2.04e-03	128	205	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	LRRK2 ACY1 LRP1B DNHD1 ASB15	2.04e-03	128	205	5	C1266044
Disease	Papillary Renal Cell Carcinoma	LRRK2 ACY1 LRP1B DNHD1 ASB15	2.04e-03	128	205	5	C1306837
Disease	Renal Cell Carcinoma	LRRK2 ACY1 LRP1B DNHD1 ASB15	2.04e-03	128	205	5	C0007134
Disease	response to hydrochlorothiazide, diastolic blood pressure change measurement	ZDHHC2 TTC6	2.08e-03	10	205	2	EFO_0005202, EFO_0006945
Disease	uveitis (implicated_via_orthology)	ANXA1 TNFRSF1A	2.54e-03	11	205	2	DOID:13141 (implicated_via_orthology)
Disease	comparative body size at age 10, self-reported	RELN LRP1B FOCAD TTBK1 RPTOR GCN1 CACNA1D ECE1 CMIP	2.82e-03	420	205	9	EFO_0009819
Disease	specific language impairment, dyslexia	CCDC136 PMFBP1	3.03e-03	12	205	2	EFO_0005424, EFO_1001510
Disease	nicotine dependence (implicated_via_orthology)	TRPC3 TRPC6	3.03e-03	12	205	2	DOID:0050742 (implicated_via_orthology)
Disease	renal fibrosis (biomarker_via_orthology)	ECE1 EDNRA	3.03e-03	12	205	2	DOID:0050855 (biomarker_via_orthology)
Disease	age at menarche	TRPC6 NR6A1 LRP1B PRDM2 RPTOR USP49 TFAP2D ANXA1 MSH5 CMIP MAPK3	3.09e-03	594	205	11	EFO_0004703
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	ATP8A2 DIAPH3	3.56e-03	13	205	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	male infertility (implicated_via_orthology)	KIT PMFBP1	3.56e-03	13	205	2	DOID:12336 (implicated_via_orthology)
Disease	Nephronophthisis	ATXN10 TTC21B	3.56e-03	13	205	2	C0687120
Disease	gallbladder cancer (is_implicated_in)	LRP1B APOB	3.56e-03	13	205	2	DOID:3121 (is_implicated_in)
Disease	Multiple Sclerosis	NLRP3 RBPJ TNFRSF1A	3.78e-03	45	205	3	C0026769
Disease	Multiple Sclerosis, Acute Fulminating	NLRP3 RBPJ TNFRSF1A	3.78e-03	45	205	3	C0751324
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	LRRK2 ACY1 LRP1B DNHD1 ASB15	3.82e-03	148	205	5	C0279702
Disease	resting heart rate	IP6K1 KLHL42 CACNA1D KRT9 DSP	3.93e-03	149	205	5	EFO_0004351
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	ATP8A2 DIAPH3	4.14e-03	14	205	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 APOB	4.14e-03	14	205	2	EFO_0004611, EFO_0008589
Disease	low density lipoprotein triglyceride measurement	TDRD15 APOB	4.75e-03	15	205	2	EFO_0009946
Disease	Aganglionosis, Colonic	ECE1 EDNRB	4.75e-03	15	205	2	C0085758
Disease	glycerol-3-phosphate measurement	ECE1 CNTNAP2	4.75e-03	15	205	2	EFO_0010488
Disease	Aganglionosis, Rectosigmoid Colon	ECE1 EDNRB	4.75e-03	15	205	2	C1257840
Disease	response to statin, LDL cholesterol change measurement	TDRD15 APOB	4.75e-03	15	205	2	EFO_0007804, GO_0036273
Disease	unipolar depression, bipolar disorder	PXDNL LRFN5 SOX6 SYNE1 PMFBP1	4.77e-03	156	205	5	EFO_0003761, MONDO_0004985
Disease	cardiovascular disease	TDRD15 SOX6 CACNA1D TFAP2D HIPK2 HSF2BP APOB CMIP PCNX1	4.88e-03	457	205	9	EFO_0000319
Disease	Crohn Disease	LRRK2 NLRP3 SMAD3	5.09e-03	50	205	3	C0010346
Disease	Keratoderma, Palmoplantar	KRT9 KRT14	5.41e-03	16	205	2	C4551675
Disease	triglycerides to total lipids in very large VLDL percentage	TDRD15 APOB CMIP	6.00e-03	53	205	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	TDRD15 APOB CMIP	6.00e-03	53	205	3	EFO_0022258
Disease	squamous cell lung carcinoma	TRPC3 ELAC2 VARS1 MSH5 FRY	6.03e-03	165	205	5	EFO_0000708
Disease	Astrocytosis	MAPK3 TNR	6.10e-03	17	205	2	C3887640
Disease	Congenital Intestinal Aganglionosis	ECE1 EDNRB	6.10e-03	17	205	2	C3661523
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 APOB	6.10e-03	17	205	2	EFO_0022232
Disease	Gliosis	MAPK3 TNR	6.10e-03	17	205	2	C0017639
Disease	type 2 diabetes mellitus (implicated_via_orthology)	OGT ADAMTS8 EDNRB MAPK3	6.26e-03	105	205	4	DOID:9352 (implicated_via_orthology)
Disease	cholesterol to total lipids in very large VLDL percentage	TDRD15 APOB CMIP	6.32e-03	54	205	3	EFO_0022244
Disease	pulmonary hypertension (implicated_via_orthology)	ECE1 EDNRA EDNRB	6.32e-03	54	205	3	DOID:6432 (implicated_via_orthology)
Disease	platelet component distribution width	STARD8 LRRK2 C2CD5 TXK RIN2 DLEC1 USP15 RHOF USP49 SYNE1 TEX11 EDNRA	6.80e-03	755	205	12	EFO_0007984
Disease	syndrome (implicated_via_orthology)	ZDHHC2 ATAD3B	6.83e-03	18	205	2	DOID:225 (implicated_via_orthology)
Disease	Hypertrophy	TRPC6 MAPK3	6.83e-03	18	205	2	C0020564
Disease	caudal middle frontal gyrus volume measurement	ZFAT FRY	6.83e-03	18	205	2	EFO_0010290
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 APOB	6.83e-03	18	205	2	EFO_0008317, EFO_0008589

Protein segments in the cluster

Peptide	Gene	Start	Entry
QEAQMQEDRRCTGYI	USP26	866	Q9BXU7
LLGKAQCLEMRQNYS	TTC21B	181	Q7Z4L5
QCLEMRQNYSGALET	TTC21B	186	Q7Z4L5
VQGHVQLRIMENYCL	TTC21B	1116	Q7Z4L5
GYILMARNKNNACGI	CTSK	306	P43235
QGVEYQAAMECLQKA	AKAP9	3071	Q99996
CLMVYNNEVVGKGRN	ADAT2	46	Q7Z6V5
QLRQREVVDLYNGMC	CTHRC1	41	Q96CG8
YLIQGLVNMCQSALQ	TNFAIP1	111	Q13829
ELYMIGCDRSQNLVD	ALKBH8	426	Q96BT7
MDINGCAAIQYVLKV	ASB4	281	Q9Y574
GRMALYQLDQQCRQI	ADAMTS8	441	Q9UP79
CEMTVNTELLGYLQV	ATXN10	311	Q9UBB4
QAQGRMCALYASLAL	GSDMD	461	P57764
MLRLLLNNGYQVEMC	ASB15	431	Q8WXK1
LCNGMRYKLLQEGDI	CMIP	46	Q8IY22
ITIVNLSDAGMYQCL	CNTN4	371	Q8IWV2
EKLNNLRDCAIQYFM	CMTR2	391	Q8IYT2
CTQQNILFMLLKGYE	CAB39	121	Q9Y376
LCVLGQNAQTMAYNI	CSDE1	656	O75534
LEVCGNALMKQYQVQ	GLE1	626	Q53GS7
DYIGINLATMNSCIN	EDNRA	351	P25101
VLDYIGINMASLNSC	EDNRB	366	P24530
NINMQDAYGRTSLCL	ANKRD55	86	Q3KP44
PVNCLQIALRMGNYE	ASB14	386	A6NK59
QLGKFARLVDYMICQ	DNHD1	516	Q96M86
VIQCLKALMNTQYGL	DIAPH3	246	Q9NSV4
NQRRLKVYMNQVCDD	ARMCX3	196	Q9UH62
QGQIKMYINEVCRET	ARMCX6	191	Q7L4S7
GYSCRLVSQNMALIL	ATP8A2	716	Q9NTI2
YSQEAMQRALIGRCQ	ADAT1	336	Q9BUB4
SYRLMQLGCLESVAN	TFAP2D	21	Q7Z6R9
LMERNNLSYDCIGRL	HMGCS1	76	Q01581
GYQLENQKRMICNII	RAG2	276	P55895
LSLQYMIRNEDGQIC	RAD1	251	O60671
RRCDMCSNYEKQLQG	RABEP1	531	Q15276
VDGTCVAVNNKYRLM	RIC1	251	Q4ADV7
LRQDRGGMIQTCEQY	PTPN5	531	P54829
QQMIISRYLLSVCGF	NPIPB12	481	F8W0I5
IILMIRYKVCNNNGQ	LRFN5	546	Q96NI6
GIQMRISRVSCLYNE	RADX	126	Q6NSI4
QKMYGISLCQAILDE	ANXA1	316	P04083
AYMKGNANLCRAIVR	ANKFY1	1051	Q9P2R3
MEDYLQGCRAALQES	PRUNE1	1	Q86TP1
EFICQRLMQGYQIIV	DEPDC5	801	O75140
TRYNQETPMEICLNG	PLD3	271	Q8IV08
IYNRNCLIELVNCQM	KIAA0100	1571	Q14667
QEYMQNCEQLLLGSS	MDN1	3156	Q9NU22
LCYNRQMELGAMISQ	GPR82	186	Q96P67
RKYIFNCLDDMAQVN	HIPK2	466	Q9H2X6
YLQKNRMSCQGIESF	LRP1B	1866	Q9NZR2
IEQRCMRYNLSAGTI	MIS18BP1	661	Q6P0N0
LTYDRLVNGMLQCVA	KIT	416	P10721
TKNRYCGQLQMIQEQ	KRT9	401	P35527
KEMGQNLRETVSYCL	MTUS1	331	Q9ULD2
ENSLEETKGRYCMQL	KRT14	356	P02533
ETKGRYCMQLAQIQE	KRT14	361	P02533
NLQYMVKACQVGSEE	MMS22L	1136	Q6ZRQ5
YITGSILRMQCDRGQ	F13B	626	P05160
SQNQKRLYIMTLGCL	NAA50	66	Q9GZZ1
ETMQEGLRLCADRNY	PCNX1	1721	Q96RV3
EMLYQCQGHRNVLEL	MKNK2	131	Q9HBH9
QNICEVGFEYMNREL	PEX2	181	P28328
AQDLIQCAMVKGYLT	PGLYRP4	326	Q96LB8
VEQGCQILDSLSYMR	FBXO39	176	Q8N4B4
LEETKGRYCMQLSQI	KRT16	361	P08779
KNNMILCQTDYEEGL	LMO3	121	Q8TAP4
DYLKNVMLERACDQN	LRRK2	706	Q5S007
VEGQNRDLMNQLCTY	METTL16	536	Q86W50
RDLMNQLCTYIRNQI	METTL16	541	Q86W50
ELLTNCYIMVQGNTV	KRR1	176	Q13601
DKQYLDCCGNLMQTL	TUBGCP5	696	Q96RT8
GMRQAAAIILNIYCS	GCN1	2166	Q92616
QEDLNCIINMKARNY	MAPK3	266	P27361
MTNLAIVNCQVYGRN	LRRC63	311	Q05C16
AQLAYSILECQIQGM	PCDH10	496	Q9P2E7
KYIQGLKNNMNCEAR	C17orf75	171	Q9HAS0
IIQRMLSCYQQGIAL	DZIP3	576	Q86Y13
FGIMLQLYAQICRIV	GPR3	206	P46089
LNGCINPVLYAAMNR	GPR84	361	Q9NQS5
YRIQGGQVDIDCLSM	RELN	1621	P78509
SLQCYRINLQMRLGG	INO80B	331	Q9C086
QMYGCRVIQKALEFI	PUM1	931	Q14671
KGEACMLLRIYQRNT	PATE3	46	B3GLJ2
QILLYNGDVDMACNF	CTSA	391	P10619
MIRNTRESDQGVYQC	PXDNL	291	A1KZ92
LMRGTILRCTKYNQE	CCDC105	356	Q8IYK2
QMEKLRNELAAYLCG	C6orf132	466	Q5T0Z8
QILYNRTMVQLGICA	EIF3C	606	Q99613
DPIRISMCQNLGYNV	FZD4	46	Q9ULV1
LKDCQQLAMLYNNRE	DNAH1	986	Q9P2D7
KALELYEQLCQRMGV	DYNC2H1	1961	Q8NCM8
LDFNIGQNRMLLCQE	EFCAB5	1266	A4FU69
GQNRMLLCQEYKDLQ	EFCAB5	1271	A4FU69
VQILYNRTMVQLGIC	EIF3CL	606	B5ME19
IANYLMEQIQDDCTG	APOB	466	P04114
YNRRNCILADEMGLG	CHD9	876	Q3L8U1
LMCSAYRNQLLNIFV	GNPAT	476	O15228
NLSINNDLNLRYCMG	EFCAB6	236	Q5THR3
NDLNLRYCMGNQEVS	EFCAB6	241	Q5THR3
DLKQYLDDCGNIINM	CDK16	246	Q00536
RLYGAILQMRSCNKE	CHKA	146	P35790
SLLEKQRIACQQMGY	CPHXL2	136	A0A1W2PPK0
ANQLMQYDQCLTKGA	GALNT7	576	Q86SF2
CTNAELVKGRQYLIM	C5	1606	P01031
MGQPCDAYQKRLLQL	DSP	131	P15924
VLKLQQRCRMYGAET	HAP1	391	P54257
LVCQRMLNQGFLKVE	FBXO28	96	Q9NVF7
ELCYEGIVDSQLRNM	ANKRD7	216	Q92527
RVYGAQNEMCLATQQ	APPL2	46	Q8NEU8
TDQDIGMYQCLATNL	CNTN6	91	Q9UQ52
IQFYNQLQVCVGVML	DNAH14	1411	Q0VDD8
LGVRVCGMQVYQLDT	IP6K1	256	Q92551
CMESINYNGVNITDL	CNTNAP2	336	Q9UHC6
LINTTDRCLLNNYMI	ECE1	381	P42892
YLCRNNTIQTMEELL	FRY	1481	Q5TBA9
DRINAQYLEVKCGAM	HAUS4	261	Q9H6D7
QQRVREVYLMNLSGC	DLEC1	1651	Q9Y238
GNIGVQMLVDLSQCY	SACS	3936	Q9NZJ4
LLSYAAALQCMGRQD	POLRMT	296	O00411
KYQEALQLCLGQNMS	IFT140	1151	Q96RY7
VLEMRGNAVVGYLQC	C2CD5	211	Q86YS7
CRNYFNLLDMLVVGV	CACNA1D	951	Q01668
SELPCQLVQMNYVGN	SERPINA6	246	P08185
IKENCMRVGLVAYSN	COL6A6	261	A6NMZ7
MRLNFGEEIQQLCLE	FOCAD	1416	Q5VW36
TALLGNDNYKQIAMC	KIFAP3	391	Q92845
GRMCYAIIQAESKQA	MIF4GD	56	A9UHW6
YDRTCNNEVVKMQRL	MED6	41	O75586
CMLQKVLLNEYNGID	PRDM2	886	Q13029
KEMQDVQGALQCYTR	OGT	406	O15294
GTMQGVYEQCEALLR	OTOG	341	Q6ZRI0
MYVLLRMACSNIQIN	OR1D2	181	P34982
ETLLMYQLQCQVLAR	MSH5	501	O43196
QSCLLQNLGLSEMYF	NLRP3	996	Q96P20
CMKAINFLNQDIRGL	NR6A1	391	Q15406
TCRLYRGNDQIMTNL	PMFBP1	876	Q8TBY8
LVCNSRILSYMGELQ	RTKN	76	Q9BST9
YLKDEQLCRLNLGMQ	RSBN1	311	Q5VWQ0
LCAYMSQGRDINLDV	VARS1	926	P26640
QQLLQQAEYCTEMGA	HSF2BP	111	O75031
MQGLSACEQIRAALY	RHOF	156	Q9HBH0
QYVQCVAGCLQLMLR	ATP6V1H	196	Q9UI12
VAGCLQLMLRVNEYR	ATP6V1H	201	Q9UI12
CCGLIDLMREYQNLK	SYNE1	2081	Q8NF91
YCQLGRNNKDLEMIE	TDRD15	981	B5MCY1
CLQTLFEQQNMYRLK	ABCC6	361	O95255
SYQELLQRKGALMCL	ABCC6	836	O95255
NYRTMCRGENSILGQ	PLD1	846	Q13393
INVNYNIMCLSREEG	RGS22	106	Q8NE09
CINAGENMKYGEQLL	NEXMIF	186	Q5QGS0
EIGREIQQLSMAGCY	FBXL18	91	Q96ME1
DMVITYGLDQLENCQ	SMG1	476	Q96Q15
YMLCTDGQQLLRQVL	ESRP2	126	Q9H6T0
LRNNIYCMAQLLDNS	OSM	146	P13725
QAMRYLRSQCLDQVG	STARD8	591	Q92502
TAMEYLNGQDCSLLL	RPTOR	1071	Q8N122
QQRMESENNKLCSLY	SOX6	76	P35712
CQYRNINRKLSAAGM	HTR7	401	P34969
LCELQLLYQGMQEEQ	CCDC136	611	Q96JN2
IYARGAQDMKCVSIQ	ACY1	106	Q03154
ACVQDAVQQYRQKMR	ATAD3B	556	Q5T9A4
ECSINGMKYQEINGR	ATP11B	421	Q9Y2G3
AMIDCLQGKQLYAVS	RNF17	1576	Q9BXT8
EVGLQVCRQGYNMLN	PRPF8	491	Q6P2Q9
LECMYANLQLQTQLA	TSACC	66	Q96A04
CLNEDYTMGLKNARN	SKA3	231	Q8IX90
MVCGIQEAAENYRKL	TRIML2	51	Q8N7C3
RVCKLIYTVMENNSG	RIN2	676	Q8WYP3
CLDSAQQGLYRKVML	ZNF100	51	Q8IYN0
VMLENYRNLASLGLC	ZFP28	131	Q8NHY6
MVENYRNLVFLGICL	ZNF880	36	Q6PDB4
QMNTSLCERIRKVYG	ZFAT	726	Q9P243
CGRNEKFNYVVMQLQ	TTBK1	96	Q5TCY1
VMLENYSNLVTVGCQ	ZNF568	76	Q3ZCX4
LAYEGRAVVCLQMGN	TTC6	316	Q86TZ1
NRYLFNCGEGVQRLM	ELAC2	81	Q9BQ52
RDISLIKQYVQRQCM	REV3L	2881	O60673
GEGAIYLFNMCLQQL	RNASEH2B	46	Q5TBB1
SLYLACALMVRGNVQ	TUBE1	341	Q9UJT0
VNQGFEAVYQLTRMC	SMAD3	356	P84022
DALRCVNNYQGMLKV	TIPRL	71	O75663
VNNYQGMLKVACAEE	TIPRL	76	O75663
LNGELSQKLQVYCDM	TNR	1156	Q92752
RNLGNTCYMNSILQV	USP49	256	Q70CQ1
VYLTELKLCENGNMN	USP15	131	Q9Y4E8
VMLENYRNLVSVGLC	ZNF470	51	Q6ECI4
PQLMRDIQVNLGYLC	NUP188	1471	Q5SRE5
RNMACCYLNLQQLDK	TEX11	461	Q8IYF3
CYGNIMERLRELNTE	STAB2	361	Q8WWQ8
GYAQQDTQEFLRCLM	USP20	226	Q9Y2K6
QSKVDMYARVLQEGC	PLCH1	326	Q4KWH8
GCQLVALNYQSEGRM	PLCH1	676	Q4KWH8
EMQQLNLEGKNYCTA	RBPJ	111	Q06330
LECTMRGVLREQYLQ	ZNFX1	736	Q9P2E3
RDKQNRTALMLGCEY	UACA	196	Q9BZF9
ELQRFQTGEKMYECN	ZNF677	201	Q86XU0
RTLYQEVMLENCGLL	ZNF264	36	O43296
QNSFQIGMLRRYEEC	ZNF253	91	O75346
IVTEFMENGCLLNYL	TXK	341	P42681
MENGCLLNYLRENKG	TXK	346	P42681
MNSGILQVFQRELIC	TRIM51G	1	A0A3B3IT33
SLLQNDAYNDCLKGM	ZUP1	371	Q96AP4
VMLENYFNLISVGCQ	ZNF484	36	Q5JVG2
VMLENYRNLVSLGIC	ZNF528	36	Q3MIS6
AYAIQLCIVSMENTG	ZDHHC2	36	Q9UIJ5
LRGAAQCYLLQTAMN	TARBP1	526	Q13395
MNSGILQVFQRELIC	TRIM49B	1	A6NDI0
VNCVDYMGQNALQLA	TRPC6	126	Q9Y210
VENLQRLCYMGLLQF	GTF3C1	966	Q12789
QNGRCLREAQYSMLA	TNFRSF1A	391	P19438
SIQAVRLNLMQNYRC	ZNF106	1801	Q9H2Y7
QMCIQIKEVGDRVNY	TRPM7	1206	Q96QT4
RNLGNTCYMNSVLQV	USP44	276	Q9H0E7
TLYQEVMLENCGLLV	ZNF805	36	Q5CZA5
GYSQQDAQEFLRCLM	USP33	266	Q8TEY7
NCVDYMGQNALQLAV	TRPC3	56	Q13507
GVFVNIQYTLRCDMK	VPS26C	111	O14972
QKNLYREVMQETCRN	ZNF669	111	Q96BR6
VNCMQLGVESNGRYI	VPS13D	961	Q5THJ4
GRLESLLNYQTMVCD	GLDC	171	P23378
LLNYQTMVCDITGLD	GLDC	176	P23378
LLSQVRLNNCLEMYR	KLHL42	121	Q9P2K6
GYMIVKCRGQQEITN	MX2	321	P20592
RKVQVQDRGQYMCTA	MXRA5	1916	Q9NR99
RKGMQIRCNISYLEE	MYO5C	1601	Q9NQX4